Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis

Benzer Materyaller

• Influence of Reduced Folate Carrier and Aminoimidazole Carboxamide Ribonucleotide Transformylase gene polymorphisms on the efficacy of methotrexate in juvenile idiopathic arthritis
  Yazar:: Bilginer, Yelda, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Generation of novel pharmacogenomic candidates in the response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype
  Yazar:: Moncrieffe, Halima, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• 5-aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis
  Yazar:: Pastore, Serena, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide.
  Yazar:: Baggott, J E, ve diğerleri
  Baskı/Yayın Bilgisi: (1986)
• Specificity of 4-aminoimidazole-5-carboxamide ribotide transformylase of Escherichia coli.
  Yazar:: Patrick, T W, ve diğerleri
  Baskı/Yayın Bilgisi: (1971)